Repositioning of bromocriptine for treatment of acute myeloid leukemia.

María Carmen Lara-CastilloJosep Maria Cornet-MasanaAmaia EtxabeAntònia Banús-MuletMiguel Ángel TorrenteMeritxell NomdedeuMarina Díaz-BeyáJordi EsteveRuth M Risueño

Published in: Journal of translational medicine (2016)

Our results support the use of bromocriptine as an anti-AML drug in a repositioning setting and the further clinical validation of this preclinical study.

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
emergency department
replacement therapy
drug induced
smoking cessation